Below are the most recent publications written about "Schizophrenia" by people in Profiles.
-
Rabasco A, Choi J, Ladis I, Arias SA, Weinstock LM, Miller I, Boudreaux ED, Camargo CA, Gaudiano BA. Who's getting care? Acute treatment utilization following an emergency department visit among adults with major psychiatric disorders and suicidal thoughts and behaviors. J Psychiatr Res. 2026 07; 198:175-181.
-
Cooper MI, Grimm AF, Adhikari S, Zeber JE, Geissler KH. Continuity of Care and Patient Outcomes in Populations With Schizophrenia: A Systematic Review. Psychiatr Serv. 2026 Mar 01; 77(3):250-260.
-
Chen AY, Simon GE, Ericson KM, Zeber JE, Qian J, Geissler KH. Guideline-Concordant Care and Clinician and Clinic Characteristics for Patients With Schizophrenia. JAMA Netw Open. 2025 12 01; 8(12):e2549130.
-
Goldwaser EL, Yuen A, Marshall W, Adhikari BM, Chiappelli J, van der Vaart A, Kvarta M, Ma Y, Du X, Gao S, Bruce H, Donnelly P, Mitchell B, Hong C, Wang DJJ, Kochunov P, Hong LE. Peripheral Microvascular and Cerebral White Matter Dysfunction in Schizophrenia: Implications of a Body-Brain Endothelial Pathophysiology. Schizophr Bull. 2025 11 10; 51(6):1658-1667.
-
Fan X, Freudenreich O, Jarskog LF, McEvoy J, Harrington A. Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial. J Clin Psychiatry. 2025 10 13; 86(4).
-
Ringeisen H, Edlund M, Guyer H, Dever J, Carpenter L, Olfson M, First M, Geiger P, Liao D, Peytchev A, Carr C, Chwastiak L, Dixon LB, Monroe-Devita M, Scott Stroup T, Swanson J, Swartz M, Gibbons R, Stambaugh L, Bareis N, Smith TE, Kessler RC. Prevalence of Past-Year Mental and Substance Use Disorders, 2021-2022. Psychiatr Serv. 2025 Aug 01; 76(8):720-728.
-
Bareis N, Edlund M, Ringeisen H, Guyer H, Dixon LB, Olfson M, Smith TE, Chwastiak L, Monroe-DeVita M, Swartz M, Swanson J, Sinclair Hancq E, Geiger P, Kreski NT, Stroup TS. Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study. Psychiatr Serv. 2025 01 01; 76(1):2-12.
-
Chaudhry IB, Husain MO, Khoso AB, Kiran T, Husain MI, Qurashi I, Rahman RU, Mehmood N, Drake R, Husain N, Deakin B. Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin. J Psychopharmacol. 2024 09; 38(9):818-826.
-
Young TR, Kumar VJ, Saranathan M. Normative Modeling of Thalamic Nuclear Volumes and Characterization of Lateralized Volume Alterations in Alzheimer's Disease Versus Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Jul; 10(7):726-739.
-
Jasuja GK, Reisman JI, Miller DR, Ansara ED, Chiulli DL, Moore T, Ourth HL, Tran MH, Smith EG, Morreale AP, McCullough MM. Complexity of patients with mental healthcare needs cared for by mental health clinical pharmacist practitioners in Veterans Affairs. Am J Health Syst Pharm. 2024 05 24; 81(11):e289-e295.